We are live on ! Find out more
PFBT

Parkside Financial Bank & Trust Portfolio holdings

AUM $1.31B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+15.28%
1 Year Est. Return
+19.14%
3 Year Est. Return
+63.35%
5 Year Est. Return
+76.33%
10 Year Est. Return
+246.44%
AUM
$319M
AUM Growth
+$31.7M
Cap. Flow
-$7.86M
Cap. Flow %
-2.47%
Top 10 Hldgs %
42.43%
Holding
1,711
New
80
Increased
897
Reduced
348
Closed
77

Top Buys

Rank Stock Value
1
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
+$1.72M
2
MSFT icon
Microsoft
MSFT
+$449K
3
UL icon
Unilever
UL
+$340K
4
PG icon
Procter & Gamble
PG
+$305K
5
GM icon
General Motors
GM
+$302K

Top Sells

Rank Stock Value
1
IWB icon
iShares Russell 1000 ETF
IWB
+$2.91M
2
TIP icon
iShares TIPS Bond ETF
TIP
+$1.98M
3
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$1.61M
4
SF
Stifel
SF
+$1.41M
5
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$690K

Sector Composition

Rank Sector Weight
1 Technology 15.57%
2 Financials 7.12%
3 Healthcare 6.15%
4 Industrials 5.22%
5 Consumer Staples 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY.RT
1701
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$0 ﹤0.01%
200
– –
TCO
1702
DELISTED
Taubman Centers Inc.
TCO
– –
-76
Closed -$3K
HDS
1703
DELISTED
HD Supply Holdings, Inc.
HDS
– –
-824
Closed -$34K
GLIBA
1704
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
– –
-74
Closed -$6K
DNKN
1705
DELISTED
Dunkin' Brands Group, Inc.
DNKN
– –
-3
Closed –
LVGO
1706
DELISTED
Livongo Health, Inc. Common Stock
LVGO
– –
-51
Closed -$7K
IMMU
1707
DELISTED
Immunomedics Inc
IMMU
– –
-75
Closed -$6K
AMTD
1708
DELISTED
TD Ameritrade Holding Corp
AMTD
– –
-23
Closed -$1K
NBL
1709
DELISTED
Noble Energy, Inc.
NBL
– –
-1,830
Closed -$16K
ETFC
1710
DELISTED
E*Trade Financial Corporation
ETFC
– –
-271
Closed -$14K
UN
1711
DELISTED
Unilever NV New York Registry Shares
UN
– –
-4,158
Closed -$251K
65 66 67 68
69

Similar funds

SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.02% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
COCM
Charter Oak Capital Management Portsmouth, New Hampshire $1.29B AUM 13.93% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Parkside Financial Bank & Trust's Q4 2020 Portfolio in Review

As of Q4 2020, Parkside Financial Bank & Trust held 1,711 positions worth $319M, up 11% from $287M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Parkside Financial Bank & Trust's Q4 2020 filing shows 80 new, 897 increased, 348 reduced and 77 closed positions. Its largest new stake was Treehouse Foods: 4,972 shares worth $211K. The largest sale was iShares Russell 1000 ETF, an estimated $2.91M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • Parkside Financial Bank & Trust's largest Q4 2020 buy was Treehouse Foods: 4,972 shares worth $211K.
  • Parkside Financial Bank & Trust added most to JP Morgan Alerian MLP Index ETN 5/24/24 in Q4 2020, an estimated $1.72M increase.
  • Parkside Financial Bank & Trust's biggest Q4 2020 reduction was iShares Russell 1000 ETF, cutting an estimated $2.91M.
  • Parkside Financial Bank & Trust fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $251K.
  • Parkside Financial Bank & Trust's ten largest holdings make up 42% of its $319M portfolio in Q4 2020.
  • Parkside Financial Bank & Trust opened 80 new positions and closed 77 in Q4 2020.
  • Parkside Financial Bank & Trust's portfolio value rose 11% quarter-over-quarter to $319M.

Based on Parkside Financial Bank & Trust's 13F filing for Q4 2020, filed 9 Feb 2021.